Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

656 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study.
Ishikawa E, Yokoyama Y, Chishima H, Kasai H, Kuniyoshi O, Kimura M, Hakamata J, Nakada H, Suehiro N, Nakaya N, Nakajima H, Ikemura S, Kawada I, Yasuda H, Terai H, Jibiki A, Kawazoe H, Soejima K, Muramatsu H, Suzuki S, Nakamura T. Ishikawa E, et al. Among authors: soejima k. Invest New Drugs. 2023 Feb;41(1):122-133. doi: 10.1007/s10637-023-01328-9. Epub 2023 Jan 13. Invest New Drugs. 2023. PMID: 36637703 Free PMC article.
Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung Cancer.
Kameyama N, Sato T, Arai D, Fujisawa D, Takeuchi M, Nakachi I, Kawada I, Yasuda H, Ikemura S, Terai H, Nukaga S, Nakano Y, Hirano T, Minematsu N, Asakura T, Kamatani T, Tanaka K, Suzuki S, Miyawaki M, Naoki K, Fukunaga K, Soejima K. Kameyama N, et al. Among authors: soejima k. JCO Oncol Pract. 2022 Dec;18(12):e1977-e1986. doi: 10.1200/OP.22.00124. Epub 2022 Nov 8. JCO Oncol Pract. 2022. PMID: 36346964
Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma.
Ebisudani T, Hamamoto J, Togasaki K, Mitsuishi A, Sugihara K, Shinozaki T, Fukushima T, Kawasaki K, Seino T, Oda M, Hanyu H, Toshimitsu K, Emoto K, Hayashi Y, Asakura K, Johnson TA, Terai H, Ikemura S, Kawada I, Ishii M, Hishida T, Asamura H, Soejima K, Nakagawa H, Fujii M, Fukunaga K, Yasuda H, Sato T. Ebisudani T, et al. Among authors: soejima k. Cell Rep. 2023 Mar 28;42(3):112212. doi: 10.1016/j.celrep.2023.112212. Epub 2023 Mar 6. Cell Rep. 2023. PMID: 36870059 Free article.
Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study.
Takata S, Morikawa K, Tanaka H, Itani H, Ishihara M, Horiuchi K, Kato Y, Ikemura S, Nakagawa H, Nakahara Y, Seki Y, Bessho A, Takahashi N, Hayashi K, Endo T, Takeyama K, Maekura T, Takigawa N, Kawase A, Endoh M, Nemoto K, Kishi K, Soejima K, Okuma Y, Yoshimura K, Saigusa D, Kanai Y, Ueda K, Togashi A, Matsutani N, Seki N. Takata S, et al. Among authors: soejima k. Ther Adv Med Oncol. 2023 Jun 5;15:17588359231177021. doi: 10.1177/17588359231177021. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37323187 Free PMC article.
Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG).
Takimoto R, Kamigaki T, Ito H, Saito M, Takizawa K, Soejima K, Yasuda H, Ohgino K, Terai H, Tomita K, Miura M, Mizukoshi E, Miyashita T, Nakamoto Y, Hayashi K, Miwa S, Kitahara M, Takeuchi A, Kimura H, Mochizuki T, Sugie H, Seino KI, Yamada T, Takeuchi S, Makita K, Naitoh K, Yasumoto K, Yoshida Y, Inoue H, Kotake K, Ohshima K, Noda SE, Okamoto M, Yoshimoto Y, Okada S, Ibe H, Oguma E, Goto S; CITEG. Takimoto R, et al. Among authors: soejima k. Cytotherapy. 2023 Nov;25(11):1229-1235. doi: 10.1016/j.jcyt.2023.06.007. Epub 2023 Jul 22. Cytotherapy. 2023. PMID: 37486281 Free article.
Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.
Horiuchi K, Ikemura S, Sato T, Shimozaki K, Okamori S, Yamada Y, Yokoyama Y, Hashimoto M, Jinzaki M, Hirai I, Funakoshi T, Mizuno R, Oya M, Hirata K, Hamamoto Y, Terai H, Yasuda H, Kawada I, Soejima K, Fukunaga K. Horiuchi K, et al. Among authors: soejima k. Oncologist. 2024 Jan 5;29(1):e108-e117. doi: 10.1093/oncolo/oyad187. Oncologist. 2024. PMID: 37590388 Free PMC article.
The First Case Report of Effective Treatment With Sotorasib for Metastatic Atypical Lung Carcinoid Harboring KRAS G12C Mutation and Aggressive Disseminated Lung Metastasis: A Case Report.
Saiki M, Omori C, Morikawa H, Shinohara K, Shimamura S, Ohkoshi H, Uchida Y, Inoue T, Kondo T, Ikemura S, Soejima K. Saiki M, et al. Among authors: soejima k. JTO Clin Res Rep. 2023 Dec 15;5(1):100620. doi: 10.1016/j.jtocrr.2023.100620. eCollection 2024 Jan. JTO Clin Res Rep. 2023. PMID: 38299192 Free PMC article.
Clinical utility of the Oncomine Dx Target Test multi-CDx system and the possibility of utilizing those original sequence data.
Saito A, Terai H, Kim TJ, Emoto K, Kawano R, Nakamura K, Hayashi H, Takaoka H, Ogata A, Kinoshita K, Ito F, Shigematsu L, Okada M, Fukushima T, Mitsuishi A, Shinozaki T, Ohgino K, Ikemura S, Yasuda H, Kawada I, Soejima K, Nishihara H, Fukunaga K. Saito A, et al. Among authors: soejima k. Cancer Med. 2024 Feb;13(4):e7077. doi: 10.1002/cam4.7077. Cancer Med. 2024. PMID: 38457233 Free PMC article.
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.
Terai H, Soejima K, Shimokawa A, Horinouchi H, Shimizu J, Hase T, Kanemaru R, Watanabe K, Ninomiya K, Aragane N, Yanagitani N, Sakata Y, Seike M, Fujimoto D, Kasajima M, Kubo A, Kusumoto S, Oyamada Y, Fujiwara K, Mori M, Hashimoto M, Shingyoji M, Kodani M, Sakamoto J, Agatsuma T, Kashiwabara K, Inomata M, Tachihara M, Tanaka K, Hayashihara K, Koyama N, Matsui K, Minato K, Jingu D, Sakashita H, Hara S, Naito T, Okada A, Tanahashi M, Sato Y, Asano K, Takeda T, Nakazawa K, Harada T, Shibata K, Kato T, Miyaoka E, Yoshino I, Gemma A, Mitsudomi T. Terai H, et al. Among authors: soejima k. JTO Clin Res Rep. 2022 Sep 1;3(11):100404. doi: 10.1016/j.jtocrr.2022.100404. eCollection 2022 Nov. JTO Clin Res Rep. 2022. PMID: 36275911 Free PMC article.
Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.
Bucci T, Romiti GF, Corica B, Shantsila A, Teo WS, Park HW, Shimizu W, Tse HF, Proietti M, Chao TF, Lip GYH; Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. Bucci T, et al. Minerva Med. 2024 May 9. doi: 10.23736/S0026-4806.24.09159-6. Online ahead of print. Minerva Med. 2024. PMID: 38727706
656 results